Your session is about to expire
← Back to Search
Blinatumomab for Acute Lymphoblastic Leukemia
Study Summary
This trial is testing a combination of two drugs to treat adults with a certain kind of leukemia. The goal is to find out if it is safe and what the best dose is.
- Acute Lymphoblastic Leukemia
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are there any recruitment opportunities available for this scientific experiment?
"According to clinicaltrials.gov, this trial is not currenlty accepting participants; the initial posting date was October 2nd 2020 and last update November 7th 2022. There are currently 2084 other trials that are actively enrolling patients though."
Could you enumerate the number of hospitals conducting this research study?
"Patients are being enrolled for this clinical trial in various locations, such as the University of Texas MD Anderson Cancer Center located in Houston, TX; University of Chicago based out of Chicago, IL and Icahn School of Medicine at Mount Sinai situated in New york City."
In what kinds of treatment regimens is Blinatumomab commonly employed?
"Blinatumomab is typically prescribed to address ophthalmia and sympathetic. Additionally, it has proven effective in treating branch retinal vein occlusion, macular edema, and certain eye conditions."
Are individuals who are 45 or older eligible to participate in this trial?
"According to the trial's prerequisites, individuals aged 18-99 are eligible for entry. For comparison, there exist 547 studies permitting minors and 1697 trials open to seniors."
What safety concerns should be taken into consideration when administering Blinatumomab?
"Due to the early stages of development, there is limited clinical data regarding Blinatumomab's efficacy and safety, leading it to receive a score of 1."
Am I eligible to subscribe to this medical experiment?
"This trial is seeking 17 adult volunteers, between the ages of 18 and 99, who are afflicted with acute lymphocytic leukemia (L1). Furthermore, eligibility requirements state that these participants must be in good health as per their ECOG PS score and have a negative pregnancy test if they are of childbearing age."
How many participants has this research project enrolled thus far?
"Unfortunately, this clinical trial is not currently enrolling patients. The research was initially published on October 2nd 2020 and edited for the last time on November 7th 2022. If you are looking for other trials, there exist 1,498 studies accepting applicants with leukemia lymphocytic acute L1 and 586 trials recruiting participants to participate in blinatumomab treatments."
Could you elaborate on the research that has been conducted revolving around Blinatumomab?
"The initial trials of blinatumomab were conducted in 2002 at Manitoba Blood & Marrow Transplant Program CancerCare Manitoba. Since then, there have been 1112 concluded clinical studies and presently 586 are still ongoing - with a plethora of these located in Houston, Texas."
Share this study with friends
Copy Link
Messenger